In the era of precision medicine, Molecular Pathology Testing has emerged as the cornerstone of modern diagnostics. As a premier Molecular Pathology Testing Factory, Shenzhen BioX Medical Co., Ltd. provides the critical infrastructure needed for genetic analysis, pathogen detection, and biomarker discovery. Our facility serves as a global hub for OEM and ODM partnerships, transforming complex biotechnological concepts into scalable clinical instruments.
Established in 2017, BioX Medical has rapidly ascended as a leader in the Shenzhen biotechnology corridor. Our mission is to bridge the gap between laboratory research and mass-market clinical application by providing robust, automated, and high-precision testing platforms.
Our OEM platforms support localized cancer screening initiatives, enabling early detection of circulating tumor DNA (ctDNA) in regional clinics, reducing the need for centralized tissue biopsies.
Providing rapid, molecular-level identification for regional health departments. Our pathogen detection systems are vital for real-time monitoring of viral outbreaks like HPV, Flu, and emerging pathogens.
Empowering local pharmacies and hospitals to offer personalized medicine by testing genetic predispositions to drug reactions, ensuring patient safety at the point of care.
Extending beyond human health, our factory supports genetic breeding and testing, providing localized tools for livestock health and crop improvement.
Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Headquartered in Shenzhen, China—a leading center for biotechnology innovation—we leverage the region's advanced manufacturing ecosystem to deliver unparalleled quality.
Our multidisciplinary team of engineers, laboratory specialists, and quality management professionals continuously invests in innovation. We implement comprehensive quality control procedures throughout design, manufacturing, testing, and inspection processes to ensure compliance with international industry standards.
Serving customers across Europe, North America, Asia-Pacific, the Middle East, Latin America, and Africa, we provide flexible OEM and ODM services for distributors and healthcare organizations seeking customized molecular testing solutions.
As a forward-thinking Molecular Pathology Testing Factory, we are committed to the following technological evolutions over the next decade:
Moving from manual sample prep to "Sample-In, Result-Out" (SIRO) systems that minimize human error and cross-contamination.
Integrating machine learning algorithms to assist pathologists in interpreting complex genomic data and identifying rare mutations.
Expanding our OEM capabilities to include Next-Generation Sequencing (NGS) and absolute quantification through Digital PCR (dPCR).
One of the primary advantages of partnering with a Custom OEM Molecular Pathology Testing Factory in China is the depth of the vertical supply chain. At BioX Medical, we manage everything from the sourcing of medical-grade plastics and PFA materials to the precision calibration of optical sensors.
We assist our global partners in meeting local CE-IVD, FDA, and NMPA requirements by providing detailed documentation and validation data.
Localized software interfaces in multiple languages with specific data management features for regional hospital systems.
Remote and on-site technical support to ensure your local service teams can maintain and repair specialized equipment.
BioX Medical
